Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1182/blood-2017-03-754119 http://scihub22266oqcxt.onion/10.1182/blood-2017-03-754119 C5813736!5813736!28416506     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28416506&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Blood 2017 ; 129 (21): 2829-35 Nephropedia Template TP {{tp|p=28416506|t=2017. Clinical updates in adult immune thrombocytopenia |pdf=|usr=}}{{28416506}} gab.com Text Clinical updates in adult immune thrombocytopenia JO: Blood http://www.kidney.de/pget.php?&tw=1&pmid=28416506 #FOAvip Immune thrombocytopenia (ITP) occurs in 2 to 4/100?000 adults and results in variable bleeding symptoms and thrombocytopenia. In the last decade, changes in our understanding of the pathophysiology of the disorder have led to the publication of new guidelines for the diagnosis and management of ITP and standards for terminology. Current evidence supports alternatives to splenectomy for second-line management of patients with persistently low platelet counts and bleeding. Long-term follow-up data suggest both efficacy and safety, in particular, for the thrombopoietin receptor agonists and the occurrence of late remissions. Follow-up of patients who have undergone splenectomy for ITP reveals significant potential risks that should be discussed with patients and may influence clinician and patient choice of second-line therapy. Novel therapeutics are in development to address ongoing treatment gaps. Twit Text FOAVip Clinical updates in adult immune thrombocytopenia ????Blood http://www.kidney.de/pget.php?&tw=1&pmid=28416506 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28416506 #FOAvip English Wikipedia <ref>{{Cite pmid|28416506}}</ref> Clinical updates in adult immune thrombocytopenia #MMPMID28416506 Lambert MP; Gernsheimer TB Blood 2017[May]; 129 (21): 2829-35 PMID28416506show ga Immune thrombocytopenia (ITP) occurs in 2 to 4/100?000 adults and results in variable bleeding symptoms and thrombocytopenia. In the last decade, changes in our understanding of the pathophysiology of the disorder have led to the publication of new guidelines for the diagnosis and management of ITP and standards for terminology. Current evidence supports alternatives to splenectomy for second-line management of patients with persistently low platelet counts and bleeding. Long-term follow-up data suggest both efficacy and safety, in particular, for the thrombopoietin receptor agonists and the occurrence of late remissions. Follow-up of patients who have undergone splenectomy for ITP reveals significant potential risks that should be discussed with patients and may influence clinician and patient choice of second-line therapy. Novel therapeutics are in development to address ongoing treatment gaps. äClinical updates in adult immune thrombocytopenia (epmc).pdf DeepDyve Pubget Overpricing